주사기로 약물을 추출하는 모습
현미경을 이용하며 연구하는 모습
검색 팝업창

IR

    Financial Information

    Statement of Financial Position

    Unit: KRW million
    Line items 2025년 2024년 2023년
    Current Assets 66,102 55,979 54,144
    Non-current Assets 114,357 107,873 107,428
    Total Assets 180,459 163,852 161,572
    Current Liabilities 61,770 28,213 59,338
    Non-current Liabilities 22,460 47,380 18,558
    Total Liabilities 84,231 75,594 77,896
    Total Equity 96,228 88,258 83,676

    Consolidated Statement of Financial Position

    Unit: KRW million
    Line items 2025년 2024년 2023년
    Current Assets 67,377 56,974 55,119
    Non-current Assets 114,899 108,574 108,140
    Total Assets 182,276 165,548 163,259
    Current Liabilities 62,020 28,547 59,687
    Non-current Liabilities 22,555 47,452 18,622
    Total Liabilities 84,574 75,999 78,310
    Total Equity 97,702 89,548 84,950

    Income Statement

    Unit: KRW million
    Line items 2025년 2024년 2023년
    Revenue 170,542 150,185 131,274
    Cost of Sales 77,697 68,603 64,726
    Gross Profit 92,845 81,582 66,548
    Operating Profit 6,023 6,630 (2,043)
    Profit Before Income Tax 6,305 6,587 (6,687)
    Net Profit for the Period 5,569 5,189 (8,421)
    Total Comprehensive Income 5,526 4,002 10,896

    Consolidated Income Statement

    Unit: KRW million
    Line items 2025년 2024년 2023년
    Revenue 175,496 156,463 135,373
    Cost of Sales 81,851 73,968 68,148
    Gross Profit 93,645 82,495 67,225
    Operating Profit 6,185 6,702 (1,989)
    Profit Before Income Tax 6,443 6,609 (6,681)
    Net Profit for the Period 5,705 5,206 (8,415)
    Total Comprehensive Income 5,710 4,019 10,901